Study of Novel Brain Toxin Associated With HIV Dementia
与艾滋病毒痴呆相关的新型脑毒素的研究
基本信息
- 批准号:7347600
- 负责人:
- 金额:$ 51.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-07 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAIDS populationAIDS/HIV problemAccountingAnti-Retroviral AgentsBiological MarkersBrainBrain InjuriesBrain PathologyCellsCerebrospinal FluidChromosome PairingChronicClassClinicalCognitionDementiaDevelopmentEncephalitisFamilyGlycosaminoglycansGrowthHIVHIV InfectionsHIV-1Heparitin SulfateHighly Active Antiretroviral TherapyImmuneImpaired cognitionInflammatoryInfusion proceduresInorganic SulfatesInvadedLaboratoriesMicrogliaModelingMonitorMononuclearNerve DegenerationNeuronsNeuropathogenesisNeurotoxinsOligosaccharidesPathologicPathway interactionsPatientsPatternPhagocytesPoisonPopulationPrevention therapyProteinsResearchRiskRodentStructureSynapsesToxinUnspecified or Sulfate Ion SulfatesVertebral columnWorkbench to bedsidemonocyteneurotoxicnovelsizesugarsulfationvolunteer
项目摘要
DESCRIPTION (provided by applicant): HIV-associated dementia (HAD) involves destruction of neurons and synapses. Although it is agreed that brain inflammatory cells, including brain microglia and invading blood monocytes, participate in this CNS-damaging pathway by release of neurotoxins, the underlying mechanisms to account for neuropathogenesis of HAD remain uncertain. We have recently found a novel class of neurotoxins released by HIV-infected mononuclear cells. Extensive background study shows that this neurotoxin family is found in the cerebrospinal fluid (CSF) of HIV/AIDS volunteers and is closely associated with degrees of cognitive impairment.
In order to uncover fundamental immuno-pathologic mechanisms of HAD, we will explore the HIV-elicited neurotoxin by examining its structural features, its mechanisms of action, and its ability to predict cognitive decline among HIV/AIDS volunteers. Further study will consider the effect of HAART on this CSF biomarker. This work represents transformational research that will help to delineate an immune pathway common to HAD and to other forms of dementia and will contribute to the development of neuroprotective treatments, which do not yet exist.
描述(由申请人提供):与HIV相关的痴呆(HAT)涉及神经元和突触的破坏。尽管人们同意,包括脑炎性细胞,包括脑部小胶质细胞和入侵血液核细胞,通过释放神经毒素参与了这种CNS损害途径,但考虑到神经病发生的基本机制仍然不确定。我们最近发现了一种由HIV感染的单核细胞释放的新型神经毒素。广泛的背景研究表明,这种神经毒素家族是在HIV/AIDS志愿者的脑脊液(CSF)中发现的,并且与认知障碍程度密切相关。
为了揭示HAD的基本免疫病理机制,我们将通过检查其结构特征,其作用机理以及预测HIV/AIDS志愿者认知能力下降的能力来探索艾滋病毒引起的神经毒素。进一步的研究将考虑HAART对此CSF生物标志物的影响。 这项工作代表了变革性研究,将有助于描述一种常见的人和其他形式的痴呆症的免疫途径,并将有助于神经保护治疗的发展,而神经保护疗法尚未存在。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dana Giulian其他文献
Dana Giulian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dana Giulian', 18)}}的其他基金
DRUG TREATMENT OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE
阿尔茨海默病脑部炎症的药物治疗
- 批准号:
7375030 - 财政年份:2005
- 资助金额:
$ 51.79万 - 项目类别:
Study of Novel Brain Toxin Associated With HIV Dementia
与艾滋病毒痴呆相关的新型脑毒素的研究
- 批准号:
6895055 - 财政年份:2005
- 资助金额:
$ 51.79万 - 项目类别:
Study of Novel Brain Toxin Associated With HIV Dementia
与艾滋病毒痴呆相关的新型脑毒素的研究
- 批准号:
7578909 - 财政年份:2005
- 资助金额:
$ 51.79万 - 项目类别:
Study of Novel Brain Toxin Associated With HIV Dementia
与艾滋病毒痴呆相关的新型脑毒素的研究
- 批准号:
7014564 - 财政年份:2005
- 资助金额:
$ 51.79万 - 项目类别:
Study of Novel Brain Toxin Associated With HIV Dementia
与艾滋病毒痴呆相关的新型脑毒素的研究
- 批准号:
7174622 - 财政年份:2005
- 资助金额:
$ 51.79万 - 项目类别:
Novel CSF biomarker to predict impaired cognition in HIV
新型脑脊液生物标志物可预测艾滋病毒认知受损
- 批准号:
6961654 - 财政年份:2004
- 资助金额:
$ 51.79万 - 项目类别:
Novel CSF biomarker to predict impaired cognition in HIV
新型脑脊液生物标志物可预测艾滋病毒认知受损
- 批准号:
6972938 - 财政年份:2004
- 资助金额:
$ 51.79万 - 项目类别:
Novel CSF biomarker to predict impaired cognition in HIV
新型脑脊液生物标志物可预测艾滋病毒认知受损
- 批准号:
7111609 - 财政年份:2004
- 资助金额:
$ 51.79万 - 项目类别:
DRUG TREATMENT OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE
阿尔茨海默病脑部炎症的药物治疗
- 批准号:
7206811 - 财政年份:2004
- 资助金额:
$ 51.79万 - 项目类别:
Novel CSF biomarker to predict impaired cognition in HIV
新型脑脊液生物标志物可预测艾滋病毒认知受损
- 批准号:
6945467 - 财政年份:2004
- 资助金额:
$ 51.79万 - 项目类别:
相似海外基金
Tracking HIV Infection and Alcohol Abuse CNS Comorbidity with Neuroimaging
通过神经影像学追踪 HIV 感染和酒精滥用中枢神经系统合并症
- 批准号:
9532537 - 财政年份:2017
- 资助金额:
$ 51.79万 - 项目类别:
The impact of marijuana use on brain and cognitive function in HIV-infected patients
吸食大麻对艾滋病毒感染者大脑和认知功能的影响
- 批准号:
9204071 - 财政年份:2016
- 资助金额:
$ 51.79万 - 项目类别:
The impact of marijuana use on brain and cognitive function in HIV-infected patients
吸食大麻对艾滋病毒感染者大脑和认知功能的影响
- 批准号:
9321496 - 财政年份:2016
- 资助金额:
$ 51.79万 - 项目类别:
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)
适应性预防策略
- 批准号:
9102262 - 财政年份:2014
- 资助金额:
$ 51.79万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8823758 - 财政年份:2014
- 资助金额:
$ 51.79万 - 项目类别: